Clinical trial
Thalidomide to Treat Oral Lesions in HIV-Infected Patients
NCT00001524 · National Institute of Dental and Craniofacial Research (NIDCR), NIH · Completed
Key facts
| NCT number | NCT00001524 |
|---|---|
| Title | Thalidomide to Treat Oral Lesions in HIV-Infected Patients |
| Official title | Evaluation of a TNF-Alpha Modulator for the Treatment of Oral Lesions in HIV/AIDS Patients |
| Lead sponsor | National Institute of Dental and Craniofacial Research (NIDCR), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acquired Immunodeficiency Syndrome, Burning Mouth Syndrome, HIV Infection |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 110 |
| Start date | Jun 1, 1996 |
| Completion | Dec 1, 2004 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: